Abstract
Purpose
To evaluate results in the palliative treatment of patients with liver metastases of uveal malignant melanoma using transarterial chemoembolization (TACE).
Materials and methods
Superselective TACE was repeatedly performed in 12 patients with liver metastases of uveal malignant melanoma. Six patients presented with solitary liver metastases (6–12 cm in size) and six patients with oligonodular metastases (n ≤ 6). The embolization suspension consisted of a maximum of 10 mg/m2 Mitomycin C, 10 ml Lipiodol, and an injection of 200–450 mg resorbable microspheres for vascular occlusion. In the follow-up, magnetic resonance imaging was performed in 3-month intervals.
Results
The TACE procedure was well tolerated in all patients without any relevant side effects. Three patients responded to TACE with a size reduction of more than 50% (partial response), five patients with stable disease, and four patients with progressive disease with an increase in volume of more than 25%. Mean survival following primary tumor treatment was 32.9 months, and after first embolization 19.5 months. Lower survival rates were recorded for the progressive group (16.5 months).
Conclusion
Repeated TACE offers a palliative treatment option in patients with oligonodular liver metastases of uveal malignant melanoma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Argawala SSk, Panikkar R, Kirkwook JM (2004) Phase I/II randomized trial of intrahepatic arterial infusion chemotherapy with cisplatin and chemoembolization with cisplatin and polyvinyl sponge in patients with ocular melanoma metastatic to the liver. Melanoma Res 14:217–222
Braun UC, Rummelt VC, Naumann GO (1998) Diffuse malignant melanoma of the uvea: a clinicohistopathologic study of 39 patients [Article in German]. Klin Monatsbl Augenheilkd 213:331–340
Cantore M, Fiorentini G, Aitini E, Davitti B, Cavazzini G, Rabbi C, et al (1994) Intraarterial hepatic carboplatin-based chemotherapy for ocular melanoma metastatic to the liver: report of phase II study. Tumori 80:37–39
Carrasco CH, Wallace S, Charnsangavej C, Papadopoulos NE, Patt XY, Mavligit GM (1986) Treatment of hepatic metastases in ocular melanoma: embolization of the hepatic artery with polyvinyl sponge and cisplatin. JAMA 255:3152–3154
Egerer G, Lehnert T, Max R, Naeher H, Keilholz U, Ho AD (2001) Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients. Int J Clin Oncol 6:25–28
Fan J, Tang ZY, Yu YQ, et al (1998) Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma. Dig Surg 15:674–678
Feldman ED, Pingpank JF, Alexander HR Jr (2004) Regional treatment options for patients with ocular melanoma metastatic to the liver. Ann Surg Oncol 11:290–297
Flaherty LE, Unger JM, Liu PY, Mertens WC, Sondak VK (1998) Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials. Am J Clin Oncol 21:568–572
Gragoudas E, Li W, Goitein M, Lane AM, Munzenrider JE, Egan KM (2002) Evidence-based estimates of outcome in patients irradiated for intraocular melanoma. Arch Ophthalmol 120:1665–1671
Hakansson L, Hakansson A, Morales O, Thorelius L, Warfving T (1997) Spherex (degradable starch microspheres) chemo-occlusion-enhancement of tumor drug concentration and therapeutic efficacy: an overview. Semin Oncol 24:S6-100–S6-109
Leyvraz S, Spataro V, Bauer J, Pampallona S, Salmon R, Dorval T, et al (1997) Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol 15:2589–2595
Livraghi T (2001) Guidelines for treatment of liver cancer. Eur J Ultrasound 13:167–176
Mavligit GM, Charnsangavej C, Carrasco H, Patt XY, Benjamin RS, Wallace S (1988) Regression of ocular melanoma metastatic to the liver after hepatic arterial chemoembolization with cisplatin and polyvinyl sponge. JAMA 260:974–976
Patel K, Sullivan K, Berd D, Mastrangelo MJ, Shields CL, Shields JA, Sato T (2005) Chemoembolization of the hepatic artery with BCNU for metastatic uveal melanoma: results of a phase II study. Melanoma Res 15:297–304
Pyrhonen S (1998) The treatment of metastatic uveal melanoma. Eur J Cancer 34(Suppl 3):S27–S30
Rivoire M, Kodjikian L, Baldo S, Kaemmerlen P, Négrier S, Grange JD (2005) Treatment of Liver Metastases from Uveal Melanoma. Ann Surg Oncol 12:1–7
Sasson AR, Sigurdson ER (2002) Surgical treatment of liver metastases. Semin Oncol 29:107–118
Schmittel A, Schuster R, Bechrakis NE, Siehl JM, Foerster MH, Thiel E, Keilholz U (2005) A two-cohort phase II clinical trial of gemcitabine plus treosulfan in patients with metastatic uveal melanoma. Melanoma Res 15:447–451
Song SY, Chung JW, Han JK, et al (2001) Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 12:313–320
Vogl TJ, Müller PK, Mack MG, Straub R, Engelmann K, Neuhaus P (1999) Liver metastases: interventional therapeutic techniques and results, state of the art. Eur Radiol 9:675–684
Vogl TJ, Trapp M, Schroeder H, et al (2000) Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 214:349–357
Wallace S, Carrasco CH, Charnsangavej C, Richli WR, Wright K, Gianturco C (1990) Hepatic artery infusion and chemoembolization in the management of liver metastases. Cardiovasc Intervent Radiol 13:153–160
Wang LQ, Persson BG, Bergqvist L, Bengmark S (1994) Influence of dearterialization on distribution of absolute tumor blood flow between hepatic artery and portal vein. Cancer 74:2454–2459
Weinreich DM, Alexander HR (2002) Transarterial perfusion of liver metastases. Semin Oncol 29:136–144
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vogl, T., Eichler, K., Zangos, S. et al. Preliminary experience with transarterial chemoembolization (TACE) in liver metastases of uveal malignant melanoma: local tumor control and survival. J Cancer Res Clin Oncol 133, 177–184 (2007). https://doi.org/10.1007/s00432-006-0155-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-006-0155-z